Retractable Technologies - RVP Company Long-Term Liabilities

retractable.com - graphic logo of issuer RVP

Retractable Technologies (RVP) relies on long-term agreements with US hospitals, which guarantees the stability of its client base. The safety syringe business is not subject to market cycles and remains crisis-resistant due to government procurement. The price action history with the 0.00 indicator demonstrates the company's development. Revenue is generated through the supply of specialized needles to clinics and emergency services worldwide.

RVP (Retractable Tech) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

Analytical breakdowns for Retractable Technologies, Inc. (RVP)

- price and consensus price forecast:
Market Chart Retractable Technologies Inc.|RVP - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Retractable Technologies|RVP - Enterprise Value
- book capitalization data:
Book Value per Share Retractable Technologies|RVP - Company Book Value|Market Value to Book Value Ratio retractable.com|RVP - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Retractable Technologies|RVP - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Retractable Technologies Inc.|RVP - Company Debts|Debt to Book Value Ratio Retractable Technologies|RVP - Company Long-Term Debt|Short-Term Debt Volume Retractable Technologies
Initial company analysis:Retractable Technologies (RVP)
Original product of Retractable Technologies

This metric aggregates all credit obligations with maturities exceeding one year, allowing for an assessment of the issuer's long-term financial stability and deleveraging pace. By analyzing the trajectory of the company's long-term debt, an investor can determine whether Retractable Technologies (RVP) possesses sufficient resources to modernize its automated needle production and execute government contracts without risking a liquidity shortage.

Competing companies

Long-Term Debt Volume intuitive.com ISRG|DHR: Company Long-Term Debts|BDX - Company Long-Term Liabilities|STE: Company Long-Term Debts|WST (West Pharma Corp) - Company Long-Term Debts|Company Long-Term Debt Baxter International|Company Long-Term Debt masimo.com (MASI)|Stevanato Group (STVN) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Teleflex Inc. (TFX)|Company Long-Term Debts MMSI|Nobel Biocare - Long-Term Debt Volume|ICU Medical, Inc. (ICUI) - Company Long-Term Debt|XRAY: Company Long-Term Indebtedness|LeMaitre Vascular - Company Long-Term Debt|Long-Term Debt Volume AtriCure Inc|STAAR Surgical Corp (STAA) - Company Long-Term Liabilities|Amount of Long-Term Liabilities NAGE|ZimVie Inc. (ZIMV) - Company Long-Term Debt|Company Long-Term Loans and Borrowings angiodynamics.com ANGO|Company Long-Term Liabilities CERS (Cerus)|Alpha Teknova - Company Long-Term Debts|MGRM: Company Long-Term Debt|STSS - Company Long-Term Liabilities|Company Long-Term Debts INFU|UTMD (utahmed.com) - Long-Term Debt|Company Long-Term Debt KORU Medical Systems, Inc. (KRMD)|Company Long-Term Indebtedness Nyxoah SA (NYXH)|Company Long-Term Liabilities Microbot Medical Inc|Amount of Long-Term Liabilities PDEX (Pro-Dex Inc.)|Company Long-Term Debt ZTEK|elutia.com - Long-Term Debt Volume|Company Long-Term Debt Milestone Scientific Inc. (MLSS)|NXGL - Company Long-Term Loans and Borrowings|Company Long-Term Debts HBIO|Long-Term Debt Femasys Corporation|Meihua Medical Technologies (MHUA) - Company Long-Term Liabilities|Amount of Long-Term Liabilities POAI|Callan JMB Inc (CJMB) - Company Long-Term Debt|Company Long-Term Loans and Borrowings Atrion Corp. (ATRI)|Company Long-Term Debts NURO (NeuroMetrix Corp)